Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2719667rdf:typepubmed:Citationlld:pubmed
pubmed-article:2719667lifeskim:mentionsumls-concept:C0039005lld:lifeskim
pubmed-article:2719667lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:2719667lifeskim:mentionsumls-concept:C0006657lld:lifeskim
pubmed-article:2719667lifeskim:mentionsumls-concept:C0042890lld:lifeskim
pubmed-article:2719667pubmed:issue2lld:pubmed
pubmed-article:2719667pubmed:dateCreated1989-6-20lld:pubmed
pubmed-article:2719667pubmed:abstractTextPig kidney mitochondrial 25-hydroxyvitamin D3 1 alpha- and 24-hydroxylase activities have been solubilized with cholate/Emulgen 911 and reconstituted with NADPH, ferredoxin reductase and ferredoxin. All three of these components are required for full catalytic activity of both enzymes. Both products were identified by co-chromatography with authentic metabolites on both normal and reverse-phase h.p.l.c. using solvent systems which were shown to separate 10-oxo-19-nor-25-hydroxyvitamin D3 from 1,25-dihydroxyvitamin D3 [1,25-(OH)2-D3]. In addition, periodate treatment of the 24,25-(OH)2-D3 product resulted in complete loss of the product as measured by protein-binding assay. Further purification by p-chloroamphetamine-Sepharose chromatography of a solubilized extract from a pig fed a normal diet increased the specific content of the cytochrome P-450 from 0.019 to 0.239 nmol/mg and the 1 alpha-hydroxylase activity from 4.75 to 268 pmol/h per mg. Activity of the 24-hydroxylase in the crude solubilized extract was 6.3 pmol/h per mg, but was undetectable after partial purification by a p-chloroamphetamine-Sepharose column. However, further fractionation of this material by DEAE-Sepharose chromatography resulted in a further increase in 1 alpha-hydroxylase activity to 430 pmol/h per mg and detection of 24-hydroxylase in a separate fraction at a level of 53 pmol/h per mg. Production of 1,25-(OH)2-D3 was linear with time up to 2 h and was dependent upon ferredoxin concentration as well as cytochrome P-450 concentration in the range of 0-40 nM. In the presence of excess ferredoxin and adequate amounts of cytochrome P-450, 1,25-(OH)2-D3 production was also dependent upon substrate concentrations in the range of 0.25 to 2.5 microM yielding an estimated Km of 1 microM. In the presence of excess substrate and ferredoxin, the catalytic-centre activity of the enzyme was estimated to be 1 h-1.lld:pubmed
pubmed-article:2719667pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:languageenglld:pubmed
pubmed-article:2719667pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:citationSubsetIMlld:pubmed
pubmed-article:2719667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2719667pubmed:statusMEDLINElld:pubmed
pubmed-article:2719667pubmed:monthAprlld:pubmed
pubmed-article:2719667pubmed:issn0264-6021lld:pubmed
pubmed-article:2719667pubmed:authorpubmed-author:GrayR WRWlld:pubmed
pubmed-article:2719667pubmed:authorpubmed-author:GhazarianJ...lld:pubmed
pubmed-article:2719667pubmed:issnTypePrintlld:pubmed
pubmed-article:2719667pubmed:day15lld:pubmed
pubmed-article:2719667pubmed:volume259lld:pubmed
pubmed-article:2719667pubmed:ownerNLMlld:pubmed
pubmed-article:2719667pubmed:authorsCompleteYlld:pubmed
pubmed-article:2719667pubmed:pagination561-8lld:pubmed
pubmed-article:2719667pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:meshHeadingpubmed-meshheading:2719667-...lld:pubmed
pubmed-article:2719667pubmed:year1989lld:pubmed
pubmed-article:2719667pubmed:articleTitleSolubilization and reconstitution of kidney 25-hydroxyvitamin D3 1 alpha- and 24-hydroxylases from vitamin D-replete pigs.lld:pubmed
pubmed-article:2719667pubmed:affiliationDepartment of Medicine, Medical College of Wisconsin, Milwaukee 53226.lld:pubmed
pubmed-article:2719667pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2719667pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2719667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2719667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2719667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2719667lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2719667lld:pubmed